
Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) – Equities researchers at Zacks Research boosted their FY2026 earnings estimates for shares of Acadia Healthcare in a research report issued on Wednesday, November 18th. Zacks Research analyst Team now forecasts that the company will earn $1.70 per share for the year, up from their prior estimate of $1.48. Zacks Research currently has a “Strong-Buy” rating on the stock. The consensus estimate for Acadia Healthcare’s current full-year earnings is $1.74 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q4 2026 earnings at $0.35 EPS, Q1 2027 earnings at $0.31 EPS, Q2 2027 earnings at $0.44 EPS, Q3 2027 earnings at $0.59 EPS, Q4 2027 earnings at $0.48 EPS, FY2027 earnings at $1.82 EPS, Q1 2028 earnings at $0.37 EPS, Q2 2028 earnings at $0.55 EPS, Q3 2028 earnings at $0.65 EPS and FY2028 earnings at $2.11 EPS.
Several other equities analysts have also issued reports on the company. Wall Street Zen upgraded Acadia Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, November 7th. Cantor Fitzgerald upped their price objective on Acadia Healthcare from $30.00 to $39.00 and gave the stock a “neutral” rating in a research report on Friday, November 6th. Raymond James Financial started coverage on Acadia Healthcare in a research note on Wednesday, November 4th. They issued a “moderate buy” rating on the stock. Royal Bank Of Canada lifted their target price on Acadia Healthcare from $31.00 to $41.00 and gave the company an “outperform” rating in a research report on Friday, November 6th. Finally, Leerink Partners lifted their target price on Acadia Healthcare from $30.00 to $33.00 and gave the company a “market perform” rating in a research report on Wednesday, September 23rd. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $32.54.
Acadia Healthcare Stock Down 0.9%
NASDAQ ACHC opened at $37.59 on Thursday. The business has a fifty day moving average price of $31.04 and a two-hundred day moving average price of $27.10. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.60 and a quick ratio of 1.60. Acadia Healthcare has a fifty-two week low of $11.43 and a fifty-two week high of $39.70. The stock has a market capitalization of $3.49 billion, a PE ratio of -3.01, a PEG ratio of 4.76 and a beta of 0.64.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.46 by $0.14. Acadia Healthcare had a negative net margin of 33.07% and a positive return on equity of 6.53%. The business had revenue of $895.31 million for the quarter, compared to analysts’ expectations of $877.76 million. During the same period last year, the firm posted $0.72 earnings per share. The firm’s quarterly revenue was up 5.1% compared to the same quarter last year.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the stock. Allworth Financial LP acquired a new stake in shares of Acadia Healthcare during the 2nd quarter valued at $45,000. Global Retirement Partners LLC bought a new position in Acadia Healthcare in the second quarter valued at about $68,000. Integrated Wealth Concepts LLC bought a new position in Acadia Healthcare in the second quarter valued at about $79,000. Quantbot Technologies LP acquired a new stake in shares of Acadia Healthcare during the second quarter valued at about $88,000. Finally, Hantz Financial Services Inc. boosted its stake in shares of Acadia Healthcare by 34.8% during the third quarter. Hantz Financial Services Inc. now owns 3,006 shares of the company’s stock valued at $83,000 after purchasing an additional 776 shares in the last quarter.
Trending Headlines about Acadia Healthcare
Here are a few of the latest headlines about ACHC:
- Positive Sentiment: Zacks raised its FY2026 EPS estimate to $1.70 from $1.48, FY2027 to $1.82 from $1.68, and FY2028 to $2.11 from $1.96. It also lifted estimates for each listed quarter from Q4 2026 through Q3 2028, including Q4 2026 to $0.35 from $0.27. Acadia Healthcare analyst estimates
About Acadia Healthcare
Acadia Healthcare Company, Inc. is a U.S. provider of behavioral health services. The company operates facilities that treat mental health conditions and substance use disorders, serving patients through inpatient, residential and outpatient care. Its services include psychiatric hospitals, specialty treatment centers, residential programs and outpatient clinics. Care may include assessment, therapy, medication management and treatment for addiction, depending on the facility and program. Founded in 2005 and headquartered in Franklin, Tennessee, Acadia serves communities across the United States.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- Amazon’s Zoox Just Joined Uber—Could That Change the Robotaxi Threat?
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
